DT2216

DT2216


DT2216 stands as a PROTAC-type protein degrader in clinical development. Its focal point is the degradation of the BCL-XL protein, an anti-apoptotic protein overexpressed in certain cancers, achieved through the Von Hippel-Lindau (VHL) E3 ligase. This development is geared towards potential antitumor activity.

Molecular structure of the compound BP-41580
    • Unit
    • Price
    • Qty
    • 5 MG
    • $180.00
    • 10 MG
    • $350.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire